These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29308660)

  • 1. Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.
    Doshi R; Singh A; Jauhar R; Meraj PM
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):369-378. PubMed ID: 29308660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Alraies MC; Kaki A; Kajy M; Blank N; Hasan R; Htun WW; Glazier JJ; Elder M; O'Neill WW; Grines CL; Schreiber T
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):536-544. PubMed ID: 31631515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Outcomes of High-risk Percutaneous Ventricular Assist Device-assisted Percutaneous Coronary Intervention, 2008-2018.
    Lemor A; Basir MB; Truesdell AG; Tamis-Holland JE; Alqarqaz M; Grines CL; Villablanca PA; Alaswad K; Pinto DS; O'Neill W
    Am J Cardiol; 2021 Oct; 156():65-71. PubMed ID: 34344515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry.
    Baumann S; Werner N; Al-Rashid F; Schäfer A; Bauer T; Sotoudeh R; Bojara W; Shamekhi J; Sinning JM; Becher T; Eder F; Akin I
    Coron Artery Dis; 2020 May; 31(3):237-242. PubMed ID: 31658135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term survival after early unloading with Impella CP
    Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass grafting or protected percutaneous coronary intervention with the Impella 2.5 device.
    Becher T; Baumann S; Eder F; Perschka S; Loßnitzer D; Fastner C; Behnes M; Doesch C; Borggrefe M; Akin I
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):360-368. PubMed ID: 28660768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Hirai T; Grantham JA; Kandzari DE; Ballard W; Brown WM; Allen KB; Kirtane AJ; Argenziano M; Yeh RW; Khabbaz K; Lombardi W; Lasala J; Kachroo P; Karmpaliotis D; Gosch KL; Salisbury AC;
    Catheter Cardiovasc Interv; 2023 Nov; 102(5):814-822. PubMed ID: 37676058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study).
    Pershad A; Fraij G; Massaro JM; David SW; Kleiman NS; Denktas AE; Wilson BH; Dixon SR; Ohman EM; Douglas PS; Moses JW; O'Neill WW
    Am J Cardiol; 2014 Sep; 114(5):657-64. PubMed ID: 25037676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    O'Neill BP; Grines C; Moses JW; Ohman EM; Lansky A; Popma J; Kapur NK; Schreiber T; Mannino S; O'Neill WW; Medjamia AM; Mahmud E
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):E501-E512. PubMed ID: 34051033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex High-Risk Indicated Percutaneous Coronary Intervention With Prophylactic Use of the Impella CP Ventricular Assist Device.
    van den Buijs DMF; van den Brink FS; Wilgenhof A; Zivelonghi C; Verouden N; Knaapen P; Sjauw KD; Vermeersch P; Nap A
    J Invasive Cardiol; 2022 Sep; 34(9):E665-E671. PubMed ID: 36001456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.